Conmed Stock Performance

CNMD Stock  USD 46.00  0.13  0.28%   
CONMED has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.74, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CONMED's returns are expected to increase less than the market. However, during the bear market, the loss of holding CONMED is expected to be smaller as well. CONMED now shows a risk of 2.49%. Please confirm CONMED total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if CONMED will be following its price patterns.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CONMED are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, CONMED is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more

Actual Historical Performance (%)

One Day Return
0.28
Five Day Return
3.09
Year To Date Return
13.52
Ten Year Return
15.75
All Time Return
13.5 K
Forward Dividend Yield
0.0174
Payout Ratio
0.1446
Last Split Factor
3:2
Forward Dividend Rate
0.8
Dividend Date
2025-10-03
1
Heres Why You Should Add CONMED Stock to Your Portfolio Now
12/04/2025
2
CONMED Valuation Review as It Exits Gastroenterology and Refocuses on Core Growth Areas
12/17/2025
3
Acquisition by David Bronson of 479 shares of CONMED subject to Rule 16b-3
01/02/2026
4
Is There Now An Opportunity In CONMED After Prolonged Share Price Weakness
01/28/2026
5
CONMED Q4 Earnings Call Highlights
01/29/2026
6
One Off US88 Million Loss And Margin Compression Test CONMED Bullish Narratives
01/30/2026
7
What To Expect From STERISs Q4 Earnings
02/03/2026
8
5 Must-Read Analyst Questions From CONMEDs Q4 Earnings Call
02/04/2026
9
Heres Why You Should Retain CONMED Stock in Your Portfolio for Now - Yahoo Finance
02/10/2026
10
Is It Time To Reassess CONMED After Its Recent Share Price Rebound
02/23/2026
Begin Period Cash Flow24.5 M
Total Cashflows From Investing Activities-21 M

CONMED Relative Risk vs. Return Landscape

If you would invest  4,450  in CONMED on November 30, 2025 and sell it today you would earn a total of  150.00  from holding CONMED or generate 3.37% return on investment over 90 days. CONMED is currently generating 0.0855% in daily expected returns and assumes 2.4877% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than CONMED, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days CONMED is expected to generate 3.28 times more return on investment than the market. However, the company is 3.28 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

CONMED Target Price Odds to finish over Current Price

The tendency of CONMED Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 46.00 90 days 46.00 
roughly 2.43
Based on a normal probability distribution, the odds of CONMED to move above the current price in 90 days from now is roughly 2.43 (This CONMED probability density function shows the probability of CONMED Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days CONMED has a beta of 0.74 suggesting as returns on the market go up, CONMED average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding CONMED will be expected to be much smaller as well. Additionally CONMED has an alpha of 0.0704, implying that it can generate a 0.0704 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   CONMED Price Density   
       Price  

Predictive Modules for CONMED

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CONMED. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
43.5646.0548.54
Details
Intrinsic
Valuation
LowRealHigh
43.1445.6348.12
Details
Naive
Forecast
LowNextHigh
44.2646.7549.23
Details
6 Analysts
Consensus
LowTargetHigh
43.1347.4052.61
Details

CONMED Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. CONMED is not an exception. The market had few large corrections towards the CONMED's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CONMED, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CONMED within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.07
β
Beta against Dow Jones0.74
σ
Overall volatility
2.12
Ir
Information ratio 0.02

CONMED Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CONMED for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CONMED can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
CONMED is unlikely to experience financial distress in the next 2 years
CONMED has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: Is It Time To Reassess CONMED After Its Recent Share Price Rebound

CONMED Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CONMED Stock often depends not only on the future outlook of the current and potential CONMED's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CONMED's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding31.1 M
Cash And Short Term Investments40.8 M

CONMED Fundamentals Growth

CONMED Stock prices reflect investors' perceptions of the future prospects and financial health of CONMED, and CONMED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CONMED Stock performance.

About CONMED Performance

By analyzing CONMED's fundamental ratios, stakeholders can gain valuable insights into CONMED's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CONMED has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CONMED has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 204.65  138.62 
Return On Tangible Assets 0.05  0.08 
Return On Capital Employed 0.06  0.10 
Return On Assets 0.02  0.02 
Return On Equity 0.05  0.07 

Things to note about CONMED performance evaluation

Checking the ongoing alerts about CONMED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CONMED help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
CONMED is unlikely to experience financial distress in the next 2 years
CONMED has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: Is It Time To Reassess CONMED After Its Recent Share Price Rebound
Evaluating CONMED's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate CONMED's stock performance include:
  • Analyzing CONMED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CONMED's stock is overvalued or undervalued compared to its peers.
  • Examining CONMED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating CONMED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CONMED's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of CONMED's stock. These opinions can provide insight into CONMED's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating CONMED's stock performance is not an exact science, and many factors can impact CONMED's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for CONMED Stock analysis

When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.